• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Serologic diagnosis and follow-up of hepatitis B].

作者信息

Frei P C, Grob P J

机构信息

Division d'immunologie et d'allergie, CHUV, Lausanne.

出版信息

Soz Praventivmed. 1998;43 Suppl 1:S10-3, S84-7. doi: 10.1007/BF02042165.

DOI:10.1007/BF02042165
PMID:9833256
Abstract

This paper is a short summary on the usefulness of two antigens (HBsAg and HBeAg), three antibodies (anti-HBc, anti-HBe and anti-HBs) and of HBV DNA, as markers for the diagnosis and the follow-up of hepatitis B. The significance of each of these markers at the various stages of disease history, a few patterns of co-existence of some of these markers and the occurrence of mutations in the core and pre-core regions of the genome are also described. The various indications for measuring HBV DNA, in addition to the classical serological markers, are also mentioned.

摘要

相似文献

1
[Serologic diagnosis and follow-up of hepatitis B].
Soz Praventivmed. 1998;43 Suppl 1:S10-3, S84-7. doi: 10.1007/BF02042165.
2
Atypical serological profiles in hepatitis B virus infection.乙型肝炎病毒感染中的非典型血清学模式。
Eur J Clin Microbiol Infect Dis. 2013 Apr;32(4):461-76. doi: 10.1007/s10096-012-1781-9. Epub 2012 Nov 29.
3
Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.股静脉血或脐带血中乙肝病毒血清学阳性标志物不应作为新生儿宫内感染的证据。
BMC Infect Dis. 2016 Aug 12;16(1):408. doi: 10.1186/s12879-016-1754-1.
4
Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection.具有既往或慢性乙型肝炎病毒感染血清学标志物的受试者的病毒血症水平。
Scand J Infect Dis. 2000;32(3):249-52. doi: 10.1080/00365540050165866.
5
Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers.基于定量检测血清标志物特征标记物建立乙型肝炎病毒感染状态的简单模型。
J Med Virol. 2015 Jun;87(6):1008-12. doi: 10.1002/jmv.24156. Epub 2015 Feb 25.
6
Challenges in hepatitis B detection among blood donors.献血者乙型肝炎检测面临的挑战。
Curr Opin Hematol. 2011 Nov;18(6):461-6. doi: 10.1097/MOH.0b013e32834bac10.
7
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.接受高效抗逆转录病毒治疗的HIV感染患者乙肝血清学标志物的演变
Clin Infect Dis. 2007 Nov 1;45(9):1221-9. doi: 10.1086/522173. Epub 2007 Sep 21.
8
Occult hepatitis B virus infection: implications in transfusion.隐匿性乙型肝炎病毒感染:输血中的影响。
Vox Sang. 2004 Feb;86(2):83-91. doi: 10.1111/j.0042-9007.2004.00406.x.
9
[Hemorrhagic vasculitis and the hepatitis B virus].
Ter Arkh. 1993;65(6):17-9.
10
Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.HBeAg和抗-HBe阳性无症状HBsAg携带者的抗-HBc滴度
Z Immunitatsforsch Immunobiol. 1978 Jun;154(3):208-17.

本文引用的文献

1
Serologic diagnosis of viral hepatitis.病毒性肝炎的血清学诊断
Med Clin North Am. 1996 Sep;80(5):929-56. doi: 10.1016/s0025-7125(05)70474-0.
2
Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery.9006名分娩女性中乙肝病毒(抗-HBc、HBsAg和抗-HBs)及丁型肝炎病毒感染的血清流行率。
Liver. 1996 Apr;16(2):110-6. doi: 10.1111/j.1600-0676.1996.tb00714.x.
3
Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations.
慢性乙型肝炎患者病情加重时病毒血症、氨基转移酶及乙型肝炎核心抗原IgM抗体的波动情况。
Liver. 1994 Aug;14(4):175-81. doi: 10.1111/j.1600-0676.1994.tb00071.x.
4
Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.对血清中广泛范围内的乙型肝炎病毒DNA进行定量分析,以研究病毒复制活性对治疗和复发感染的反应。
Hepatology. 1995 Jun;21(6):1492-9.
5
Hepatitis B virus precore/core variation and interferon therapy.
Hepatology. 1995 Nov;22(5):1355-62.